Tolerance Through Mixed Chimerism (Sip-Tego)

NCT06972069 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Kidney Failure
Transplant Recipient (Kidney)
Transplant Tolerance
Immunosuppresion
Immunosuppression After Kidney Transplantation

Interventions

PROCEDURE: Combined Kidney/Bone Marrow Transplant
PROCEDURE: Donation of Kidney / Bone Marrow
DRUG: Conditioning Regimen (Rituxan, Siplizumab, Cyclophosphamide, Tegoprubart)

Sponsor

Tatsuo Kawai, MD, PhD

Collaborators

[object Object]
[object Object]